Teva and Active Biotech complete enrollment in phase III ALLEGRO clinical trial of laquinimod Nov. 19, 2008
Preclinical activity of PF-03800130 shows benefit in bipolar disorder-associated mood symptoms Nov. 18, 2008
RSS